VIR
Vir Biotechnology, Inc.$10.14-0.14 (-1.36%)Prev Close$10.28·MCap$1.65B·P/E—·Vol91.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
30
$20.77M
◆
Net Activity
Net Seller
$20.77M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Vir Biotechnology, Inc. (VIR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 30 insider sales totaling $20.77M. The most recent insider transaction was by De Backer Marianne (director, officer: President and CEO), who sold $664.4K worth of shares on Apr 7, 2026. Vir Biotechnology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.65B.
VIR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | De Backer Marianne | director, officer: President and CEO | Sell | 72,559 | $9.16 | $664.4K | 948,145 |
| Apr 2, 2026 | SATO VICKI L | director | Sell | 22,000 | $9.07 | $199.6K | 1,100,391 |
| Mar 3, 2026 | SATO VICKI L | director | Sell | 22,000 | $9.51 | $209.2K | 1,122,591 |
| Feb 26, 2026 | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 14,762 | $9.53 | $140.7K | 1,020,704 |
| Feb 26, 2026 | Eisner Mark | officer: EVP and Chief Medical Officer | Sell | 3,505 | $9.69 | $34.0K | 155,913 |
| Feb 26, 2026 | SATO VICKI L | director | Sell | 42,377 | $9.75 | $413.4K | 1,144,591 |
| Feb 24, 2026 | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 19,039 | $7.45 | $141.9K | 1,035,466 |
| Feb 24, 2026 | Eisner Mark | officer: EVP and Chief Medical Officer | Sell | 2,089 | $7.45 | $15.6K | 157,529 |
| Feb 18, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 1,530 | $7.79 | $11.9K | 0 |
| Feb 3, 2026 | SATO VICKI L | director | Sell | 22,000 | $7.71 | $169.7K | 1,144,391 |
| Jan 5, 2026 | SATO VICKI L | director | Sell | 22,000 | $5.93 | $130.4K | 1,166,391 |
| Dec 3, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 191,854 | $5.98 | $1.15M | 13,728,924 |
| Dec 2, 2025 | SATO VICKI L | Director | Sell | 22,000 | $6.00 | $132.1K | 1,188,391 |
| Dec 1, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 189,431 | $6.41 | $1.21M | 13,982,271 |
| Nov 26, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 463,774 | $6.27 | $2.91M | 14,346,180 |
| Nov 4, 2025 | SATO VICKI L | Director | Sell | 22,000 | $5.64 | $124.0K | 1,210,391 |
| Oct 30, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 24,553 | $6.50 | $159.7K | 14,574,083 |
| Oct 28, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 113,099 | $6.01 | $679.9K | 14,664,939 |
| Oct 24, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 298,649 | $6.07 | $1.81M | 14,866,018 |
| Oct 22, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 330,210 | $6.23 | $2.06M | 15,119,959 |
| Oct 17, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 29,515 | $6.08 | $179.6K | 15,353,338 |
| Oct 14, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 251,360 | $6.14 | $1.54M | 15,372,309 |
| Oct 9, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 538,375 | $5.99 | $3.22M | 16,087,611 |
| Oct 7, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 524,297 | $5.57 | $2.92M | 16,233,699 |
| Oct 2, 2025 | SATO VICKI L | Director | Sell | 22,000 | $5.84 | $128.4K | 1,232,391 |
| Sep 3, 2025 | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.8K | 1,254,391 |
| Aug 4, 2025 | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.7K | 1,276,391 |
| Jul 17, 2025 | Eisner Mark | EVP and Chief Medical Officer | Sell | 10,382 | $5.47 | $56.8K | 108,204 |
| Jul 2, 2025 | SATO VICKI L | Director | Sell | 22,000 | $5.10 | $112.2K | 1,298,391 |
| Jun 2, 2025 | Napolitano Janet | Director | Sell | 3,200 | $5.05 | $16.1K | 16,416 |
| Apr 4, 2025 | De Backer Marianne | Chief Executive Officer | Sell | 79,712 | $5.95 | $474.2K | 769,505 |
| Feb 25, 2025 | De Backer Marianne | Chief Executive Officer | Sell | 16,122 | $9.45 | $152.4K | 849,217 |
| Feb 25, 2025 | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 14,168 | $9.45 | $133.9K | 117,901 |
| Feb 25, 2025 | SCANGOS GEORGE A | Director | Sell | 10,056 | $9.45 | $95.1K | 698,239 |
| Feb 19, 2025 | SCANGOS GEORGE A | Director | Sell | 10,964 | $9.81 | $107.6K | 708,295 |
| Jan 8, 2025 | SATO VICKI L | Director | Sell | 10,960 | $12.52 | $137.2K | 1,312,391 |
| Sep 10, 2024 | Napolitano Janet | Director | Sell | 12,190 | $7.80 | $95.0K | 11,616-51% |
| Jun 12, 2024 | Ramasastry Saira | Director | Sell | 4,000 | $10.95 | $43.8K | 14,619 |
| Apr 4, 2024 | De Backer Marianne | Chief Executive Officer | Sell | 72,995 | $9.46 | $690.4K | 678,457 |
| Apr 2, 2024 | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 2,711 | $10.05 | $27.3K | 132,069 |
| Mar 28, 2024 | Lee Sung | EVP & Chief Financial Officer | Sell | 6,008 | $9.89 | $59.4K | 100,492 |
| Feb 26, 2024 | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 12,296 | $10.05 | $123.5K | 134,780 |
| Feb 26, 2024 | Pang Phillip | EVP & Chief Medical Officer | Sell | 14,568 | $10.05 | $146.3K | 250,111 |
| Feb 26, 2024 | SCANGOS GEORGE A | Director | Sell | 27,750 | $11.07 | $307.3K | 130,711 |
| Feb 20, 2024 | SCANGOS GEORGE A | Director | Sell | 27,750 | $10.23 | $283.8K | 157,611 |
| Feb 16, 2024 | Pang Phillip | EVP & Chief Medical Officer | Sell | 3,321 | $10.24 | $34.0K | 264,679 |
| Jul 5, 2023 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 700 | $25.11 | $17.6K | 16,684,041 |
| Jul 3, 2023 | SATO VICKI L | Director | Sell | 18,000 | $24.66 | $443.9K | 1,315,351 |
| Jun 30, 2023 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 96,952 | $25.17 | $2.44M | 16,774,683 |
| Jun 22, 2023 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 9,902 | $25.18 | $249.3K | 16,781,692 |
Showing 1–50 of 206
1 / 5
VIR Insider Buying Activity
The following table shows recent insider purchases of Vir Biotechnology, Inc. (VIR) stock reported via SEC Form 4 filings.
No insider buying activity found for VIR in the last 12 months.
VIR Insider Selling Activity
The following table shows recent insider sales of Vir Biotechnology, Inc. (VIR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | De Backer Marianne | director, officer: President and CEO | Sell | 72,559 | $9.16 | $664.4K | 948,145 |
| Apr 2, 2026 | SATO VICKI L | director | Sell | 22,000 | $9.07 | $199.6K | 1,100,391 |
| Mar 3, 2026 | SATO VICKI L | director | Sell | 22,000 | $9.51 | $209.2K | 1,122,591 |
| Feb 26, 2026 | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 14,762 | $9.53 | $140.7K | 1,020,704 |
| Feb 26, 2026 | Eisner Mark | officer: EVP and Chief Medical Officer | Sell | 3,505 | $9.69 | $34.0K | 155,913 |
| Feb 26, 2026 | SATO VICKI L | director | Sell | 42,377 | $9.75 | $413.4K | 1,144,591 |
| Feb 24, 2026 | De Backer Marianne | director, officer: Chief Executive Officer | Sell | 19,039 | $7.45 | $141.9K | 1,035,466 |
| Feb 24, 2026 | Eisner Mark | officer: EVP and Chief Medical Officer | Sell | 2,089 | $7.45 | $15.6K | 157,529 |
| Feb 18, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 1,530 | $7.79 | $11.9K | 0 |
| Feb 3, 2026 | SATO VICKI L | director | Sell | 22,000 | $7.71 | $169.7K | 1,144,391 |
| Jan 5, 2026 | SATO VICKI L | director | Sell | 22,000 | $5.93 | $130.4K | 1,166,391 |
| Dec 3, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 191,854 | $5.98 | $1.15M | 13,728,924 |
| Dec 2, 2025 | SATO VICKI L | Director | Sell | 22,000 | $6.00 | $132.1K | 1,188,391 |
| Dec 1, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 189,431 | $6.41 | $1.21M | 13,982,271 |
| Nov 26, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 463,774 | $6.27 | $2.91M | 14,346,180 |
| Nov 4, 2025 | SATO VICKI L | Director | Sell | 22,000 | $5.64 | $124.0K | 1,210,391 |
| Oct 30, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 24,553 | $6.50 | $159.7K | 14,574,083 |
| Oct 28, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 113,099 | $6.01 | $679.9K | 14,664,939 |
| Oct 24, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 298,649 | $6.07 | $1.81M | 14,866,018 |
| Oct 22, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 330,210 | $6.23 | $2.06M | 15,119,959 |
| Oct 17, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 29,515 | $6.08 | $179.6K | 15,353,338 |
| Oct 14, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 251,360 | $6.14 | $1.54M | 15,372,309 |
| Oct 9, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 538,375 | $5.99 | $3.22M | 16,087,611 |
| Oct 7, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 524,297 | $5.57 | $2.92M | 16,233,699 |
| Oct 2, 2025 | SATO VICKI L | Director | Sell | 22,000 | $5.84 | $128.4K | 1,232,391 |
| Sep 3, 2025 | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.8K | 1,254,391 |
| Aug 4, 2025 | SATO VICKI L | Director | Sell | 22,000 | $4.99 | $109.7K | 1,276,391 |
| Jul 17, 2025 | Eisner Mark | EVP and Chief Medical Officer | Sell | 10,382 | $5.47 | $56.8K | 108,204 |
| Jul 2, 2025 | SATO VICKI L | Director | Sell | 22,000 | $5.10 | $112.2K | 1,298,391 |
| Jun 2, 2025 | Napolitano Janet | Director | Sell | 3,200 | $5.05 | $16.1K | 16,416 |
| Apr 4, 2025 | De Backer Marianne | Chief Executive Officer | Sell | 79,712 | $5.95 | $474.2K | 769,505 |
| Feb 25, 2025 | De Backer Marianne | Chief Executive Officer | Sell | 16,122 | $9.45 | $152.4K | 849,217 |
| Feb 25, 2025 | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 14,168 | $9.45 | $133.9K | 117,901 |
| Feb 25, 2025 | SCANGOS GEORGE A | Director | Sell | 10,056 | $9.45 | $95.1K | 698,239 |
| Feb 19, 2025 | SCANGOS GEORGE A | Director | Sell | 10,964 | $9.81 | $107.6K | 708,295 |
| Jan 8, 2025 | SATO VICKI L | Director | Sell | 10,960 | $12.52 | $137.2K | 1,312,391 |
| Sep 10, 2024 | Napolitano Janet | Director | Sell | 12,190 | $7.80 | $95.0K | 11,616-51% |
| Jun 12, 2024 | Ramasastry Saira | Director | Sell | 4,000 | $10.95 | $43.8K | 14,619 |
| Apr 4, 2024 | De Backer Marianne | Chief Executive Officer | Sell | 72,995 | $9.46 | $690.4K | 678,457 |
| Apr 2, 2024 | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 2,711 | $10.05 | $27.3K | 132,069 |
| Mar 28, 2024 | Lee Sung | EVP & Chief Financial Officer | Sell | 6,008 | $9.89 | $59.4K | 100,492 |
| Feb 26, 2024 | HANLY ANN M. | EVP & Chief Technology Officer | Sell | 12,296 | $10.05 | $123.5K | 134,780 |
| Feb 26, 2024 | Pang Phillip | EVP & Chief Medical Officer | Sell | 14,568 | $10.05 | $146.3K | 250,111 |
| Feb 26, 2024 | SCANGOS GEORGE A | Director | Sell | 27,750 | $11.07 | $307.3K | 130,711 |
| Feb 20, 2024 | SCANGOS GEORGE A | Director | Sell | 27,750 | $10.23 | $283.8K | 157,611 |
| Feb 16, 2024 | Pang Phillip | EVP & Chief Medical Officer | Sell | 3,321 | $10.24 | $34.0K | 264,679 |
| Jul 5, 2023 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 700 | $25.11 | $17.6K | 16,684,041 |
| Jul 3, 2023 | SATO VICKI L | Director | Sell | 18,000 | $24.66 | $443.9K | 1,315,351 |
| Jun 30, 2023 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 96,952 | $25.17 | $2.44M | 16,774,683 |
| Jun 22, 2023 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | 9,902 | $25.18 | $249.3K | 16,781,692 |
VIR Insiders
Similar Stocks to VIR
VRTX
Vertex Pharmaceuticals Incorporated
$425.23-1.23%
$109.41B
REGN
Regeneron Pharmaceuticals, Inc.
$698.90-4.48%
$76.03B
ALNY
Alnylam Pharmaceuticals, Inc.
$301.40-0.16%
$40.31B
RVMD
Revolution Medicines, Inc.
$142.09-1.68%
$30.23B
INSM
Insmed Incorporated
$135.60+0.47%
$29.13B
UTHR
United Therapeutics Corporation
$572.40+0.54%
$25.13B
MRNA
Moderna, Inc.
$45.86-2.49%
$21.42B
RPRX
Royalty Pharma plc
$49.84+0.65%
$21.20B